AstraZeneca's Vaccine Candidate Produces Antibodies and T-Cell Protection for Up to One Year Medicine & Technology Oct 26, 2020 With AstraZeneca's vaccine trials resuming worldwide, results have shown good immune responses in young and older adults alike. However, trials are yet to resume in the United States as volunteers await their second dose.
‘Morbid’ Alien Theory: Extraterrestrials Haven’t Contacted Humans As They’re Destroyed by Gamma-Ray Bursts
Earth's Magnetic Field Nearly Collapsed 600 Million Years Ago, Sparking Evolution of More Complex Life
Functional Human Brain Cells Made From Salt and Water Mark Significant Step in Iontronic Neuromorphic Computing
Sunscreen Myths Debunked; Expert Warns Against 'Dangerous' Sun Protection Ideas That Only Puts One at Added Risk
SPACE ‘Cosmic Glitch’ in Einstein’s Theory of General Relativity Could Be Explained in This New Scientific Tweak [Study]
SPACE Is Mars Like Earth? NASA Rover Finds Substantial Amounts of Manganese on the Red Planet's Gale Crater
SPACE Eta Aquarids 2024: Halley's Comet Meteor Shower To Peak This Weekend; Here's How To Watch the Cosmic Light Show